Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes
Clinical trial NCT01646320 · COMPLETED
Trial details
- NCT number
- NCT01646320
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2014-08-01
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.